FDA daily

FDA daily for Saturday, August 1, 2026

In this issue: 1 shortage update, 1 approval and 9 label changes.

Drug shortages

FDA date:

FDA updated 1 shortage entry on Fri, Jul 31: 1 resolved.

Browse drug shortages in FDA data →

Drug and biologic approvals

FDA date:

On Sat, Jul 25 FDA approved no new applications and 1 supplement to existing ones.

  • DYNA-HEX 2

    XTTRIUM · CHLORHEXIDINE GLUCONATE

    NDA019422Drug (NDA)Over-the-counter
Browse drug and biologic approvals in FDA data →

Label updates

FDA date:

9 drug labels took effect on Sat, Jul 18. Below: those, and labels carrying a boxed warning.

Browse label updates in FDA data →

FDA did not answer for Device recalls, Clearances, Food and supplement recalls, Drug recalls while this issue was written; those sections will fill in on a later visit.

How the FDA daily is written

Every issue is written from FDA's public data (openFDA) and nothing else: the counts, names, firms and reasons are FDA's own. openFDA posts each kind of record on its own delay, so each section covers one FDA date and says which. Shortages cover yesterday; approvals, drug and device recalls, and food and supplement recalls cover a week ago; device clearances and label changes cover two weeks ago. Every FDA date appears in exactly one issue. Complete response letters appear the day after FDA publishes a batch.

Subscribe with any feed reader, or point an email tool at the RSS feed to send each issue as a newsletter. Search any drug, device or company across every FDA dataset in the FDA data explorer.

Read FDA's day. Stock your practice.

Join free with your NPI: wholesale pricing from verified vendors, with the FDA and state rules for each category one click away.

Data from openFDA, FDA's public API. FDA says not to rely on it to make decisions about medical care and to treat every result as unvalidated; confirm against FDA's own record and the product labeling. Not medical or legal advice.